SCHEMBL3076022

SCHEMBL3076022

C=CN(CC(=O)O)OC(C)N

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
BLM P54132 1/20 0.33
SLC6A3 Q01959 1/20 0.33
MEN1 O00255 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32
GABRA3 P34903 2/20 0.32
GABRA2 P47869 2/20 0.32
GABRB2 P47870 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2163378 0.76 ALDH1A1 (0.33) BLMNFKB1
SCHEMBL165060 0.74
SCHEMBL5528131 0.72 SLC6A2 (0.38) SLC6A2SLC6A4BLMSLC6A3MEN1
SCHEMBL8735298 0.71 TDP1 (0.31) SLC6A2SLC6A4BLMSLC6A3TSHR
SCHEMBL4013690 0.70
Ammonia Solution, Strong SCHEMBL27472350 0.69 EYA2 (0.30)
SCHEMBL3260596 0.64 PLA2G2A (0.41) BLMMEN1TSHRKMT2A
SCHEMBL1049789 0.64 KMT2A (0.34) SLC6A2SLC6A4BLMSLC6A3MEN1
Hydrochloric Acid SCHEMBL4943209 0.63 KMT2A (0.33) SLC6A2SLC6A4BLMSLC6A3MEN1
SCHEMBL676800 0.62 GABRP (0.42) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4175478-B1 METHODS OF INCREASING ALMOND YIELD VALENT USA LLC (US) 2025-12-17 EP claimed
EP-4099814-A1 METHOD FOR IMPROVING THE STABILITY OF A CULTIVATED PLANT Omnicult Farmconcept GmbH (DE) 2022-12-14 EP claimed
CN-115067357-A Composite fruit setting agent and application thereof in sweet cherry planting 青岛市农业科学研究院 2022-09-20 CN claimed
US-20210285938-A1 GASOTRANSMITTER METABOLITES AND ALZHEIMER'S DISEASE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2021-09-16 US claimed
WO-2021156169-A1 METHOD FOR IMPROVING THE STABILITY OF A CULTIVATED PLANT OMNICULT FARMCONCEPT GMBH (DE) 2021-08-12 WO claimed
EP-3269243-B9 PREPARATION METHOD FOR PESTICIDE NANO SOLID DISPERSION INST OF ENVIRONMENT AND SUSTAINABLE DEVELOPMENT IN AGRICULTURE CHINESE ACADEMY OF AGRICULTURAL SCIEN (CN) 2020-07-29 EP claimed
EP-2745678-B1 METHOD FOR CONTROLLING SEXUALITY OF HOP KIRIN HOLDINGS KK (JP) 2017-10-11 EP claimed
EP-2015633-B1 A METHOD TO REDUCE SPRAY DRIFT DURING APPLICATION OF PESTICIDES AND CROP PROTECTION AGENTS DOW AGROSCIENCES LLC (US) 2016-04-06 EP claimed
WO-2015002612-A9 METHODS OF SCREENING USING INTERSTITIAL CELLS AND METHODS OF SUPPRESSING PROLIFERATION AND/OR TRANSFORMATION OF INTERSTITIAL CELLS SINGAPORE HEALTH SERVICES PTE LTD (SG) 2015-02-26 WO claimed
WO-2015002612-A1 METHODS OF SCREENING USING INTERSTITIAL CELLS AND METHODS OF SUPPRESSING PROLIFERATION AND/OR TRANSFORMATION OF INTERSTITIAL CELLS SINGAPORE HEALTH SERVICES PTE LTD (SG) 2015-01-08 WO claimed
EP-1534069-B1 PROMOTING EARLY ESTABLISHMENT OF POTATO CROPS BY ETHYLENE INHIBITORS VALENT BIOSCIENCES CORP (US) 2009-04-08 EP claimed
EP-1518118-B1 SAMPLE COLLECTION DEVICE COMPRISING A HYDROPHILIC MEMBRANE FOR SEPARATING PARTICULATE MATERIAL IN THE SAMPLE YORKTEST LAB LTD (GB) 2007-10-03 EP claimed
EP-0982989-B1 A PROCESS FOR INHIBITING STEM ELONGATION IN BULBOUS PLANTS VALENT BIOSCIENCES CORP (US) 2004-08-18 EP claimed
EP-1028627-B1 AMINOETHOXYVINYLGLYCINE IN COMBINATION WITH MEPIQUAT CHLORIDE BASF CORP (US) 2002-05-22 EP claimed
EP-0767607-B1 USE OF COMPOUNDS WHICH INHIBIT EHTYLENE BIOSYNTHESIS IN HIGHER PLANTS FOR SOIL IMPROVEMENT BASF AG (DE) 1998-11-25 EP claimed
EP-0750489-B1 INHIBITION OF HAIR GROWTH HANDELMAN JOSEPH H (US) 1998-11-18 EP claimed
EP-0750489-A1 INHIBITION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1997-01-02 EP claimed
US-5455234-A Applying inhibitor of cysteine pathway enzyme topically to skin; cosmetic for face, arms, legs AHLUWALIA GURPREET S (US) 1995-10-03 US claimed
WO-1995024885-A1 INHIBITION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1995-09-21 WO claimed
EP-3741853-B1 METHODS OF CELL SELECTION AND MODIFYING CELL METABOLISM LONZA AG (CH) 2023-11-22 EP disclosed
US-20230174971-A1 METHODS OF CELL SELECTION AND MODIFYING CELL METABOLISM LONZA LTD (CH) 2023-06-08 US disclosed
EP-4099814-A1 METHOD FOR IMPROVING THE STABILITY OF A CULTIVATED PLANT Omnicult Farmconcept GmbH (DE) 2022-12-14 EP disclosed
CN-115067357-A Composite fruit setting agent and application thereof in sweet cherry planting 青岛市农业科学研究院 2022-09-20 CN disclosed
CN-115067357-A Composite fruit setting agent and application thereof in sweet cherry planting 青岛市农业科学研究院 2022-09-20 CN disclosed
US-20210285938-A1 GASOTRANSMITTER METABOLITES AND ALZHEIMER'S DISEASE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2021-09-16 US disclosed
US-20210274824-A1 Nutritional Treatment for Cancer THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-09-09 US disclosed
WO-2021156169-A1 METHOD FOR IMPROVING THE STABILITY OF A CULTIVATED PLANT OMNICULT FARMCONCEPT GMBH (DE) 2021-08-12 WO disclosed
US-10973251-B1 Nutritional treatment for cancer THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-04-13 US disclosed
EP-3645720-B1 METHODS OF CELL SELECTION AND MODIFYING CELL METABOLISM LONZA AG (CH) 2021-03-10 EP disclosed
CN-112021165-A A hybridization method of Curcuma plant 广州普邦园林股份有限公司 2020-12-04 CN disclosed
EP-3741853-A1 METHODS OF CELL SELECTION AND MODIFYING CELL METABOLISM Lonza Ltd. (CH) 2020-11-25 EP disclosed
US-20190336462-A1 USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-11-07 US disclosed
US-10335382-B2 Use of hydrogen sulfide synthesis inhibitors for cancer therapy THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-07-02 US disclosed
EP-3352586-A1 NUTRITIONAL TREATMENT FOR CANCER The Board Of Trustees Of The Leland Stanford Junior University (US) 2018-08-01 EP disclosed
WO-2017053328-A1 NUTRITIONAL TREATMENT FOR CANCER THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2017-03-30 WO disclosed
WO-2017044535-A1 METHODS FOR INCREASING OIL PALM YIELD VALENT BIOSCIENCES CORPORATION (US) 2017-03-16 WO disclosed
WO-2015138307-A8 METHODS FOR INCREASING OIL PALM YIELD VALENT BIOSCIENCES CORPORATION (US) 2016-10-13 WO disclosed
US-20160095831-A1 USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2016-04-07 US disclosed
WO-2015138307-A1 METHODS FOR INCREASING OIL PALM YIELD VALENT BIOSCIENCE CORPORATION (US) 2015-09-17 WO disclosed
CN-104542953-A Special preservative for thick-skin muskmelons UNIV SHAANXI NORMAL 2015-04-29 CN disclosed
WO-2015002612-A9 METHODS OF SCREENING USING INTERSTITIAL CELLS AND METHODS OF SUPPRESSING PROLIFERATION AND/OR TRANSFORMATION OF INTERSTITIAL CELLS SINGAPORE HEALTH SERVICES PTE LTD (SG) 2015-02-26 WO disclosed
WO-2015002612-A1 METHODS OF SCREENING USING INTERSTITIAL CELLS AND METHODS OF SUPPRESSING PROLIFERATION AND/OR TRANSFORMATION OF INTERSTITIAL CELLS SINGAPORE HEALTH SERVICES PTE LTD (SG) 2015-01-08 WO disclosed
WO-2014201446-A2 USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR THE THERAPY OF COLORECTAL CANCERS HELLMICH MARK (US) 2014-12-18 WO disclosed
US-7790460-B2 Method for the regeneration of cotton MONSANTO TECHNOLOGY LLC (US) 2010-09-07 US disclosed
WO-2008054815-A3 ENHANCED AMINO ACID FORMULATIONS VALENT BIOSCIENCES CORP (US) 2009-04-30 WO disclosed
EP-2046117-A2 MULTICOMPARTMENT GRANULATE FORMULATIONS FOR ACTIVE SUBSTANCES Bayer Technology Services GmbH (DE) 2009-04-15 EP disclosed
WO-2008054815-A2 ENHANCED AMINO ACID FORMULATIONS VALENT BIOSCIENCES CORPORATION (US) 2008-05-08 WO disclosed
WO-2008009361-A2 MULTICOMPARTMENT GRANULATE FORMULATIONS FOR ACTIVE SUBSTANCES BAYER TECHNOLOGY SERVICES GMBH (DE) 2008-01-24 WO disclosed
EP-1606306-A2 STEROID SPIROLACTONIZATION Pharmacia Corporation (US) 2005-12-21 EP disclosed
US-20050044592-A1 Plant growth modulation NELISSEN HILDE (BE) 2005-02-24 US disclosed
EP-1472356-A2 PLANT GROWTH MODULATION BY DRL1 AND OTHER PROTEINS OF THE ELONGATOR COMPLEX Vlaams Interuniversitair Instituut voor Biotechnologie vzw (BE) 2004-11-03 EP disclosed
WO-2004085458-A2 STEROID SPIROLACTONIZATION PHARMACIA CORPORATION (US) 2004-10-07 WO disclosed
EP-0982989-B1 A PROCESS FOR INHIBITING STEM ELONGATION IN BULBOUS PLANTS VALENT BIOSCIENCES CORP (US) 2004-08-18 EP disclosed
EP-1017269-A4 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS UNIV PENNSYLVANIA (US) 2004-05-12 EP disclosed
US-20040087030-A1 Method for the regeneration of cotton MONSANTO TECHNOLOGY LLC 2004-05-06 US disclosed
WO-2003066852-A2 PLANT GROWTH MODULATION BY DRL1 AND OTHER PROTEINS OF THE ELONGATOR COMPLEX VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW (BE) 2003-08-14 WO disclosed
WO-2001090162-A9 CRYSTAL STRUCTURE DATA OF CYSTALYSIN AND USE THEREOF FOR THE DESIGN AND PREPARATION OF INHIBITOR MOLECULES MAX PLANCK GESELLSCHAFT (DE) 2002-09-19 WO disclosed
US-6355778-B1 AN AMINO ACID SEQUENCE ENCODING A PLANT HORMONE; FOR QUANTITY AND QUALITY OF FOOD, FRUITS, VEGETABLES AND FLOWERS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2002-03-12 US disclosed
EP-1159425-A1 DNA SEQUENCE OF A PROTEIN THAT IS SIMILAR TO FKBP Sympore GmbH (DE) 2001-12-05 EP disclosed
WO-2001090162-A1 CRYSTAL STRUCTURE DATA OF CYSTALYSIN AND USE THEREOF FOR THE DESIGN AND PREPARATION OF INHIBITOR MOLECULES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2001-11-29 WO disclosed
EP-1158000-A1 Crystal structure data of cystalysin and use thereof for the design and preparation of inhibitor molecules Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2001-11-28 EP disclosed
WO-2001020973-A2 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2001-03-29 WO disclosed
WO-2000050598-A1 DNA SEQUENCE OF A PROTEIN THAT IS SIMILAR TO FKBP SYMPORE GMBH (DE) 2000-08-31 WO disclosed
WO-2000044221-A1 USE OF TRANSGENIC PLANTS OVEREXPRESSING THE enod40 GENE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) 2000-08-03 WO disclosed
EP-1017269-A1 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2000-07-12 EP disclosed
WO-2000036911-A2 METHOD FOR THE REGENERATION OF COTTON MONSANTO TECHNOLOGY LLC (US) 2000-06-29 WO disclosed
EP-0982989-A1 A PROCESS FOR INHIBITING STEM ELONGATION IN BULBOUS PLANTS Abbott Laboratories (US) 2000-03-08 EP disclosed
US-5955652-A Plant genes for sensitivity to ethylene and pathogens THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1999-09-21 US disclosed
EP-0750489-B1 INHIBITION OF HAIR GROWTH HANDELMAN JOSEPH H (US) 1998-11-18 EP disclosed
WO-1998041083-A1 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1998-09-24 WO disclosed
WO-1998028979-A1 A PROCESS FOR INHIBITING STEM ELONGATION IN BULBOUS PLANTS ABBOTT LABORATORIES (US) 1998-07-09 WO disclosed
EP-0763060-A4 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS UNIV PENNSYLVANIA (US) 1998-06-17 EP disclosed
US-5674701-A ADMINISTERING AN INHIBITORY AMOUNT OF ETHYLENE; SCREENING FOR ETHYLENE INSENSITIVITY; INOCULATING WITH PATHOGEN; SCREENING FOR DISEASE TOLERANCE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1997-10-07 US disclosed
US-5650553-A IDENTIFICATION OF NUCLEIC ACID SEQUENCES IMPARTING DISEASE TOLERANCE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1997-07-22 US disclosed
EP-0763060-A1 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1997-03-19 EP disclosed
US-5602322-A Constitutitive triple response gene and mutations THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1997-02-11 US disclosed
WO-1995035318-A1 PLANT GENES FOR SENSITIVITY TO ETHYLENE AND PATHOGENS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1995-12-28 WO disclosed
EP-0501326-B1 Use of oxime ether derivatives for the bioregulation of plants BASF AG (DE) 1995-10-11 EP disclosed
US-5455234-A Applying inhibitor of cysteine pathway enzyme topically to skin; cosmetic for face, arms, legs AHLUWALIA GURPREET S (US) 1995-10-03 US disclosed
US-5444166-A ISOLATED NUCLEIC ACID SEQUENCE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1995-08-22 US disclosed
US-5367065-A Constitutive triple response gene and mutations THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1994-11-22 US disclosed
WO-1994003047-A1 CONSTITUTIVE TRIPLE RESPONSE GENE AND MUTATIONS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1994-02-17 WO disclosed
WO-1993025067-A1 METHOD FOR IDENTIFYING PLANT PATHOGEN TOLERANCE THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1993-12-23 WO disclosed
EP-0501326-A1 Use of oxime ether derivatives for the bioregulation of plants BASF Aktiengesellschaft (DE) 1992-09-02 EP disclosed
EP-0243834-B1 SUBSTITUTED OXIME ETHERS; THEIR USE AS BIOREGULATORS FOR LOWERING THE ENDOGENE ETHYLENE LEVEL IN PLANTS BASF Aktiengesellschaft (DE) 1991-05-02 EP disclosed
EP-0243834-A2 Substituted oxime ethers; their use as bioregulators for lowering the endogene ethylene level in plants BASF Aktiengesellschaft (DE) 1987-11-04 EP disclosed
EP-0211398-A2 Substituted N-acyl-alpha-amino acid esters, their use as bioregulators, especially for lowering the endogenic ethylene level in plants BASF Aktiengesellschaft (DE) 1987-02-25 EP disclosed
EP-0211398-A2 Substituted N-acyl-alpha-amino acid esters, their use as bioregulators, especially for lowering the endogenic ethylene level in plants BASF Aktiengesellschaft (DE) 1987-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190336462-A1 USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY CBS, CTH, HCCS SLC6A2 3526/4885SLC6A4 1745/4885BLM 2857/4885
US-20160095831-A1 USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY CBS, CTH, HCCS SLC6A2 3526/4885SLC6A4 1745/4885BLM 2857/4885
US-10335382-B2 Use of hydrogen sulfide synthesis inhibitors for cancer therapy CBS, CTH, HCCS SLC6A2 3526/4885SLC6A4 1745/4885BLM 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.